AnaptysBio, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ECOR1 CAPITAL, LLC | 02/14/2025 | 7.87 M | $104.24 M | 1.01% | 27.25% |
FMR LLC | 02/13/2025 | 3.03 M | $40.12 M | -8.43% | 10.49% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.55 M | $33.74 M | 16.89% | 8.82% |
VANGUARD GROUP INC | 02/11/2025 | 1.84 M | $24.41 M | 8.45% | 6.38% |
FAIRMOUNT FUNDS MANAGEMENT LLC | 02/14/2025 | 1.82 M | $24.05 M | 100.00% | 6.29% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 1.57 M | $20.84 M | -28.76% | 5.45% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.33 M | $17.62 M | 0.00% | 4.61% |
02/14/2025 | 1.30 M | $17.21 M | 100.00% | 4.50% | |
STATE STREET CORP | 02/14/2025 | 1.29 M | $17.02 M | 41.89% | 4.45% |
CAMBER CAPITAL MANAGEMENT LP | 02/14/2025 | 1.25 M | $16.55 M | 100.00% | 4.33% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 925,007 | $12.25 M | 0.20% | 3.20% |
FIRST LIGHT ASSET MANAGEMENT, LLC | 02/14/2025 | 868,882 | $11.50 M | -8.36% | 3.01% |
PALO ALTO INVESTORS LP | 02/14/2025 | 843,971 | $11.17 M | 0.00% | 2.92% |
SANOFI | 02/14/2025 | 821,917 | $10.88 M | 100.00% | 2.84% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 781,100 | $10.34 M | 371.11% | 2.70% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 486,597 | $6.44 M | 4.55% | 1.68% |
WOODLINE PARTNERS LP | 02/14/2025 | 485,073 | $6.42 M | 5.46% | 1.68% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 419,106 | $5.55 M | 19.62% | 1.45% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 414,000 | $5.48 M | 100.00% | 1.43% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 402,300 | $5.33 M | 168.74% | 1.39% |
5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 357,733 | $4.74 M | 0.00% | 1.24% |
FRANKLIN RESOURCES INC | 02/12/2025 | 354,370 | $4.69 M | 0.00% | 1.23% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 353,300 | $4.68 M | 215.73% | 1.22% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 352,034 | $4.66 M | 66.39% | 1.22% |
VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 334,450 | $4.43 M | 40.97% | 1.16% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 331,758 | $4.39 M | -30.22% | 1.15% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 310,800 | $4.11 M | -23.13% | 1.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 293,700 | $3.89 M | 96.85% | 1.02% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 293,300 | $3.88 M | 58.11% | 1.02% |
JENNISON ASSOCIATES LLC | 01/24/2025 | 269,131 | $3.56 M | 1.60% | 0.93% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 250,000 | $3.31 M | -28.57% | 0.87% |
ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 215,454 | $2.85 M | 184.41% | 0.75% |
02/14/2025 | 215,000 | $2.85 M | 100.00% | 0.74% | |
LMR PARTNERS LLP | 02/14/2025 | 213,300 | $2.82 M | 100.00% | 0.74% |
ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 206,200 | $2.73 M | 100.00% | 0.71% |
D. E. SHAW & CO., INC. | 02/14/2025 | 197,107 | $2.61 M | -12.06% | 0.68% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 193,200 | $2.56 M | -3.59% | 0.67% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 166,054 | $2.20 M | 3.58% | 0.57% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 146,517 | $1.94 M | -55.81% | 0.51% |
LMR PARTNERS LLP | 02/14/2025 | 140,722 | $1.86 M | 100.00% | 0.49% |
SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 132,927 | $1.76 M | 100.00% | 0.46% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 125,070 | $1.66 M | 135.86% | 0.43% |
JPMORGAN CHASE & CO | 02/12/2025 | 114,939 | $1.52 M | 240.62% | 0.40% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 106,079 | $1.40 M | 100.00% | 0.37% |
02/14/2025 | 100,000 | $1.32 M | 100.00% | 0.35% | |
MACQUARIE GROUP LTD | 02/14/2025 | 93,732 | $1.24 M | 0.00% | 0.32% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 89,700 | $1.19 M | -24.30% | 0.31% |
JANE STREET GROUP, LLC | 02/14/2025 | 88,800 | $1.18 M | 77.60% | 0.31% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 87,513 | $1.16 M | -49.48% | 0.30% |
BARCLAYS PLC | 02/13/2025 | 83,567 | $1.11 M | 88.64% | 0.29% |
AnaptysBio, Inc. institutional Ownership - FAQ's
During the previous two years, 195 institutional investors and hedge funds held shares of AnaptysBio, Inc.. The most heavily invested institutionals were:
EcoR1 Capital, LLC: 7.87 M
FMR LLC: 3.03 M
BlackRock Funding, Inc. /DE: 2.55 M
VANGUARD GROUP INC: 1.84 M
Fairmount Funds Management LLC: 1.82 M
Frazier Life Sciences Management, L.P.: 1.57 M
122.58% of AnaptysBio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 38.88 M shares in the last 24 months. This purchase volume represents approximately $594.87 M in transactions.